Merck & Co., Inc. (MRK) Capital expenditures 2016–2025
Merck & Co., Inc. (MRK) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$4.1BFY2025 · since FY2016: $1.6B → $4.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.1B | +21.9% |
| FY2024 | $3.4B | -12.7% |
| FY2023 | $3.9B | -12.0% |
| FY2022 | $4.4B | -1.3% |
| FY2021 | $4.4B | +0.4% |
| FY2020 | $4.4B | +31.5% |
| FY2019 | $3.4B | +28.8% |
| FY2018 | $2.6B | +38.5% |
| FY2017 | $1.9B | +17.0% |
| FY2016 | $1.6B | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice